Specific IgE response in patients with brucellosis

Area of Science:

• Immunology
• Infectious Diseases
• Microbiology

Background:

• Brucellosis is a significant zoonotic infection with varied clinical presentations.
• Differentiating acute from chronic brucellosis is crucial for effective treatment and management.
• Serological markers are vital for diagnosing brucellosis and understanding immune responses.

Purpose of the Study:

• To investigate the utility of brucella-specific immunoglobulin E (IgE) as a serological marker for differentiating acute and chronic brucellosis.
• To compare IgE antibody responses with other brucella-specific antibodies (IgG, IgM, IgA) and microagglutination test (MAT) results.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was employed to detect and quantify brucella-specific IgE, IgG, IgM, and IgA antibodies.
• Sera from patients with acute brucellosis, chronic brucellosis, other bacterial infections, and healthy controls were analyzed.
• Results were compared with microagglutination test (MAT) findings.

Main Results:

• Elevated brucella-specific IgE antibodies were detected in a high percentage of patients with both acute (89%) and chronic (81%) brucellosis.
• Predominant antibody isotypes varied between acute (IgG, IgM, IgA, IgE, IgG1, IgG3) and chronic (IgG, IgA, IgE, IgG4) brucellosis.
• Brucella-specific IgE was found in patients with brucellosis but did not differentiate between acute and chronic stages.

Conclusions:

• Brucella-specific IgE antibodies are present in both acute and chronic brucellosis.
• IgE antibody detection alone is insufficient to distinguish between acute and chronic brucellosis.
• Further research into combined serological markers may be necessary for improved diagnostic discrimination.